GSK Investigational Site

North Little Rock, Arkansas 72117

0 studies enrolling now · 9 studies all time

What they study most

Bipolar Disorder, Cirrhosis, Liver, Dermatitis, Atopic, Hepatitis A, Infections, Rotavirus, Irritable Bowel Syndrome (IBS), Irritable Colon, Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease

Studies at this site

• Phase 2b Study of GSK4532990 in Adults With NASH — Running, not enrolling
• A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis — Stopped early
• Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis — Completed
• Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children — Completed
• Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects — Completed
• Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA — Completed
• Bipolar Study in Adults at Least 18 Years of Age — Completed
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed
• Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) — Completed